Kate Haviland, CHIEF OPERATING OFFICER at Blueprint Medicines Corp (BPMC), sold 5,534 shares at $56.18 ($325K) on 2022-03-07, disclosed to the SEC on 2022-03-08.
Seasonal sale ($325k) by CHIEF OPERATING OFFICER — this insider has traded BPMC in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.27 | 1,719 | $104K | 31.9% |
| 2 | $60.27 | 1,719 | $104K | 31.9% |
| 3 | $56.18 | 1,048 | $59K | 18.1% |
| 4 | $56.18 | 1,048 | $59K | 18.1% |
| Total | $58.72 avg | 5,534 | $325K | 100% |
| Filing → |
| BPMC | SELL | 2025-01-23 | $319K | — | Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $2.3M | — | Filing → |